Search research articles
Contact Us
Filters
Showing results (281-290 of 305) with videos related to
Page
of 31
Sort By:
Vaccine
|
August 23, 2025
Humoral immune response to Covid-19 vaccination in patients with cancer - Results from the ANRS0001S COV-POPART study
Liem Binh Luong Nguyen, Lyvia Magloire, Alexis François, et al.
The Lancet. Infectious Diseases
|
March 23, 2013
AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial
Janet E McElhaney, Jiri Beran, Jeanne-Marie Devaster, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
August 12, 2017
2015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: results from the I-MOVE+ project
Marc Rondy, Amparo Larrauri, Itziar Casado, et al.
Iscience
|
August 6, 2024
Cytokine profile of anti-spike CD4<sup>+</sup>T cells predicts humoral and CD8<sup>+</sup>T cell responses after anti-SARS-CoV-2 mRNA vaccination
Nadine Benhamouda, Anissa Besbes, Rebecca Bauer, et al.
Scientific Reports
|
November 27, 2022
Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years
Christine Durier, Laetitia Ninove, Maeva Lefebvre, et al.
Joint Bone Spine
|
June 28, 2011
TNF alpha antagonist therapy and safety monitoring
Thao Pham, Hervé Bachelez, Jean-Marie Berthelot, et al.
The Lancet. Infectious Diseases
|
February 8, 2020
PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study
Sodiomon B Sirima, Laura Richert, Arnaud Chêne, et al.
JAMA Network Open
|
April 23, 2024
Serum and Salivary IgG and IgA Response After COVID-19 Messenger RNA Vaccination
Guy Gorochov, Jacques Ropers, Odile Launay, et al.
Frontiers in Immunology
|
July 17, 2020
Global Perspectives on Immunization During Pregnancy and Priorities for Future Research and Development: An International Consensus Statement
Bahaa Abu-Raya, Kirsten Maertens, Kathryn M Edwards, et al.
Medicine
|
February 13, 2016
The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled Trial
Warren Dinges, Pierre-Marie Girard, Daniel Podzamczer, et al.
Page
of 31
Search research articles
Search
Showing results (281-290 of 305) with videos related to
Sort By:
Page
of 31
Vaccine
|
August 23, 2025
Humoral immune response to Covid-19 vaccination in patients with cancer - Results from the ANRS0001S COV-POPART study
Liem Binh Luong Nguyen, Lyvia Magloire, Alexis François, et al.
The Lancet. Infectious Diseases
|
March 23, 2013
AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial
Janet E McElhaney, Jiri Beran, Jeanne-Marie Devaster, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
August 12, 2017
2015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: results from the I-MOVE+ project
Marc Rondy, Amparo Larrauri, Itziar Casado, et al.
Iscience
|
August 6, 2024
Cytokine profile of anti-spike CD4<sup>+</sup>T cells predicts humoral and CD8<sup>+</sup>T cell responses after anti-SARS-CoV-2 mRNA vaccination
Nadine Benhamouda, Anissa Besbes, Rebecca Bauer, et al.
Scientific Reports
|
November 27, 2022
Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years
Christine Durier, Laetitia Ninove, Maeva Lefebvre, et al.
Joint Bone Spine
|
June 28, 2011
TNF alpha antagonist therapy and safety monitoring
Thao Pham, Hervé Bachelez, Jean-Marie Berthelot, et al.
The Lancet. Infectious Diseases
|
February 8, 2020
PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study
Sodiomon B Sirima, Laura Richert, Arnaud Chêne, et al.
JAMA Network Open
|
April 23, 2024
Serum and Salivary IgG and IgA Response After COVID-19 Messenger RNA Vaccination
Guy Gorochov, Jacques Ropers, Odile Launay, et al.
Frontiers in Immunology
|
July 17, 2020
Global Perspectives on Immunization During Pregnancy and Priorities for Future Research and Development: An International Consensus Statement
Bahaa Abu-Raya, Kirsten Maertens, Kathryn M Edwards, et al.
Medicine
|
February 13, 2016
The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled Trial
Warren Dinges, Pierre-Marie Girard, Daniel Podzamczer, et al.
Page
of 31